Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 3142-3145

  Wang, Guan Qing ^a,d,e   Suzutani, Tatsuo ^b   Yamamoto, Yumiko ^a   Fukui, Yoshiko ^a   Nozawa, Naoki ^a   Schmid, D Scott ^c   Kurane, Ichiro ^a   Inoue, Naoki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^e XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL FREE SYSTEM; CELL LINE; COCULTURE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER CELL LINE; TITRIMETRY; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS INFECTION;

ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; GENES, REPORTER; HERPESVIRUS 3, HUMAN; LUCIFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC;

EID: 33748706611     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00342-06     Document Type: Article

References (34)

1. Arvin, A. M. 2002. Antiviral therapy for varicella and herpes zoster. Semin. Pediatr. Infect. Dis. 13:12-21.
2. Black, J. B., N. Inoue, K. Kite-Powell, S. Zaki, and P. E. Pellett. 1993. Frequent isolation of human herpesvirus 7 from saliva. Virus Res. 29:91-98.
3. Brockman, W. W., and D. Nathans. 1974. The isolation of simian virus 40 variants with specifically altered genomes. Proc. Natl. Acad. Sci. USA 71: 942-946.
4. Cohen, J. I., and S. E. Straus. 2001. Varicella-zoster virus and its replication, p. 2707-2730. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
5. Cohrs, R. J., M. P. Hurley, and D. H. Gilden. 2003. Array analysis of viral gene transcription during lytic infection of cells in tissue culture with varicella-zoster virus. J. Virol. 77:11718-11732.
6. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
7. Field, A. K., and K. K. Biron. 1994. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7:1-13.
8. Gilbert, C., J. Bestman-Smith, and G. Boivin. 2002. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist. Updates 5:88-114.
9. Grose, C., and P. A. Brunel. 1978. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect. Immun. 19:199-203.
10. Inoue, N., T. Spira, L. Lam, J. L. Corchero, and W. Luo. 2004. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. J. Med. Virol. 74:202-206.
11. Inoue, N., J. Winter, R. B. Lal, M. K. Offermann, and S. Koyano. 2003. Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J. Virol. 77:8147-8152.
12. Kennedy, P. G., E. Grinfeld, M. Craigon, K. Vierlinger, D. Roy, T. Forster, and P. Ghazal. 2005. Transcriptomal analysis of varicella-zoster virus infection using long oligonucleotide-based microarrays. J. Gen. Virol. 86:2673-2684.
13. Kern, E. R., N. L. Kushner, C. B. Hartline, S. L. Williams-Aziz, E. A. Harden, S. Zhou, J. Zemlicka, and M. N. Prichard. 2005. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob. Agents Chemother. 49:1039-1045.
14. Krug, L. T., V. P. Pozharskaya, Y. Yu, N. Inoue, and M. K. Ottermann. 2004. Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid. J. Virol. 78:8359-8371.
15. Lopez, C., P. Pellett, J. Stewart, C. Goldsmith, K. Sanderlin, J. Black, D. Warfield, and P. Feorino. 1988. Characteristics of human herpesvirus-6. J. Infect. Dis. 157:1271-1273.
16. Meier, J. L., X. Luo, M. Sawadogo, and S. E. Straus. 1994. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol. Cell. Biol. 14:6896-6906.
17. Michael, E. J., K. M. Kuck, and P. R. Kinchington. 1998. Anatomy of the varicella-zoster virus open-reading frame 4 promoter. J. Infect. Dis. 178(Suppl. 1):S27-S33.
18. Morfin, F., D. Thouvenot, M. Turenne-Tessier, B. Lina, M. Aymard, and T. Ooka. 1999. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob. Agents Chemother. 43:2412-2416.
19. Rahaus, M., N. Desloges, M. Yang, W. T. Ruyechan, and M. H. Wolff. 2003. Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication. J. Gen. Virol. 84:2957-2967.
20. Schang, L. M. 2005. Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs. Curr. Drug Targets Infect. Disord. 5:29-37.
21. Schnute, M. E., M. M. Cudahy, R. J. Brideau, F. L. Homa, T. A. Hopkins, M. L. Knechtel, N. L. Oien, T. W. Pitts, R. A. Poorman, M. W. Wathen, and J. L. Wieber. 2005. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases. J. Med. Chem. 48:5794-5804.
22. Shigeta, S., S. Mori, T. Yokota, K. Konno, and E. De Clercq. 1986. Characterization of a varicella-zoster virus variant with altered thymidine kinase activity. Antimicrob. Agents Chemother. 29:1053-1058.
23. Shigeta, S., T. Yokota, T. Iwabuchi, M. Baba, K. Konno, M. Ogata, and E. De Clercq. 1983. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J. Infect. Dis. 147:576-584.
24. Shiraki, K., H. Ochiai, J. Namazue, T. Okuno, S. Ogino, K. Hayashi, K. Yamanishi, and M. Takahashi. 1992. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus. Antiviral Res. 18: 209-214.
25. Snoeck, R., G. Andrei, and E. De Clercq. 1999. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 57:187-206.
26. Snoeck, R., D. Schols, C. Sadzot-Delvaux, J. M. Cloes, G. Andrei, E. De Clercq, J. Piette, and B. Rentier. 1992. Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents. J. Virol. Methods 38:243-254.
27. Standring-Cox, R., T. H. Bacon, and B. A. Howard. 1996. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir. J. Virol. Methods 56:3-11.
28. Suzutani, T., M. Ogasawara, T. Shibaki, and M. Azuma. 2000. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to antiherpesvirus nucleosides. Antiviral Res. 45:79-82.
29. Suzutani, T., M. Saijo, M. Nagamine, M. Ogasawara, and M. Azuma. 2000. Rapid phenotypic characterization method for herpes simplex virus and varicella-zoster virus thymidine kinases to screen for acyclovir-resistant viral infection. J. Clin. Microbiol. 38:1839-1844.
30. Taylor, S. L., P. R. Kinchington, A. Brooks, and J. F. Moffat. 2004. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J. Virol. 78:2853-2862.
31. Villarreal, E. C. 2003. Current and potential therapies for the treatment of herpes-virus infections. Prog. Drug Res. 60:263-307.
32. Visalli, R. J., and M. van Zeijl. 2003. DNA encapsidation as a target for anti-herpesvirus drug therapy. Antiviral Res. 59:73-87.
33. Visse, B., B. Dumont, J. M. Huraux, and A. M. Fillet. 1998. Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS. J. Infect. Dis. 178(Suppl. 1):S55-S57.
34. Weinberg, A., J. C. Clark, S. A. Schneider, B. Forghani, and M. J. Levin. 1996. Improved detection of varicella zoster infection with a spin amplification shell vial technique and blind passage. Clin. Diagn. Virol. 5:61-65.